Ovarian PRP: Ovarian Rejuvenation, Evidence and Risks

3 min readOct 14, 2026By Dr. Arnold Mahesan

Ovarian platelet-rich plasma, or PRP, is an experimental intervention studied in patients with low ovarian reserve, poor response to IVF, or primary ovarian insufficiency.

You may encounter it under the name “ovarian rejuvenation.” That name does not establish that the treatment reverses ovarian aging, restores the egg supply, or improves the chance of having a baby.

What is ovarian PRP?

A blood sample is processed to produce a platelet-rich preparation. This is injected into the ovaries, generally with ultrasound guidance.

Platelets release substances involved in tissue repair. Whether injecting PRP into the ovaries produces a meaningful fertility benefit is a separate question that requires clinical evidence.

Ovarian PRP is different from uterine PRP, which is placed into or around the uterine lining.

Does ovarian rejuvenation work?

Current evidence does not establish ovarian PRP as a reliable way to improve egg quality or increase live birth.

Reports of changes in AMH, follicle counts, or retrieved egg numbers can be interesting, but these are not equivalent to showing that more patients have babies. Small studies, differences in preparation and treatment, and uncontrolled comparisons make the findings difficult to interpret.

A before-and-after improvement can also reflect ordinary cycle variation. Randomized studies are important for determining whether the intervention itself made a difference. The 2024 PROVA randomized trial did not find improved mature egg yield in the poor-response patients studied. ESHRE’s add-on recommendations advise against routine intraovarian PRP. Results from one patient group should not be generalized to every diagnosis.

What should patients with low AMH ask?

The discussion should address:

  • What evidence applies to patients with your diagnosis and age?
  • Does it measure live birth or only laboratory and hormone changes?
  • How does the proposed procedure differ from those studied?
  • Could it delay an IVF attempt or another option?
  • What are the uncertainties and alternatives?

A low AMH result does not, by itself, establish that PRP is appropriate.

What are the risks?

Using your own blood does not eliminate procedural risks. Potential concerns include bleeding, infection, ovarian injury, and sedation-related complications when sedation is used.

Long-term safety information is limited. Ask who performs the procedure, how the preparation is handled, what monitoring is arranged, and how complications would be managed.

Discuss the evidence before deciding

A consultation can help you interpret the claims you have seen and compare PRP with other options in your situation.

Dr. Arnold Mahesan can review your ovarian reserve and previous treatment history as part of that discussion. Any proposed intervention should have a clear explanation of its investigational status, risks, and uncertain benefits.

Contact Dr. Arnold’s office to discuss your individual prospects and current treatment fees.

Dr. Arnold Mahesan

By Dr. Arnold Mahesan

Fertility SpecialistBeverly Hills Babies

Dr. Arnold Mahesan is a board-certified fertility specialist with extensive experience in IVF, fertility treatment, and gestational surrogacy. He is committed to helping intended parents navigate their journey with personalized care and expert guidance.

Ready to Begin Your Journey?

We’re here for you when you’re ready to begin. Simply click below to begin your journey.

Request a Fertility Consultation